Insight Molecular Diagnostics (IMDX) Net Income towards Common Stockholders Growth (3y) (2018 - 2026)
Insight Molecular Diagnostics (IMDX) Net Income towards Common Stockholders Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.70 Bn | 209.63 Bn | 8.34 Bn | 8.89% |
| 2 | Danaher | 140.15 Bn | 135.80 Bn | 3.61 Bn | -7.69% |
| 3 | Idexx Laboratories | 46.31 Bn | 46.11 Bn | 779.09 Mn | 14.70% |
| 4 | Agilent Technologies | 39.74 Bn | 37.93 Bn | 990.00 Mn | 3.93% |
| 5 | Iqvia Holdings | 39.38 Bn | 37.30 Bn | 1.44 Bn | -6.41% |
| 6 | Natera | 38.78 Bn | 37.68 Bn | 696.04 Mn | 14.66% |
| 7 | Illumina | 29.96 Bn | 28.79 Bn | 770.00 Mn | 42.35% |
| 8 | Mettler Toledo International | 28.60 Bn | 28.55 Bn | 650.22 Mn | 2.87% |
| 9 | Quest Diagnostics | 26.26 Bn | 25.64 Bn | 1.03 Bn | 10.22% |
| 10 | Insight Molecular Diagnostics | 171.73 Mn | 142.80 Mn | 15,000.00 | -1,219.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,219.38% |
| Dec 31, 2025 | -65.42% |
| Sep 30, 2025 | -4.08% |
| Jun 30, 2025 | -5.18% |
| Mar 31, 2025 | 13.45% |
| Dec 31, 2024 | 2.26% |
| Sep 30, 2024 | 0.75% |
| Jun 30, 2024 | 24.11% |
| Mar 31, 2024 | -33.55% |
| Dec 31, 2023 | -26.04% |
| Sep 30, 2023 | 0.47% |
| Jun 30, 2023 | -7.71% |
| Mar 31, 2023 | 26.00% |
| Dec 31, 2022 | 46.47% |
| Sep 30, 2022 | -22.59% |
| Jun 30, 2022 | -15.86% |
| Mar 31, 2022 | -38.61% |
| Dec 31, 2021 | -14.45% |
| Sep 30, 2021 | -64.77% |
| Jun 30, 2021 | -34.76% |